Skip to main content
Clinical Trials/NL-OMON37585
NL-OMON37585
Completed
Phase 2

Phase II study: Radiofrequency ablation of locally advanced pancreatic cancer - Phase II: RFA of pancreatic cancer

niversitair Medisch Centrum Utrecht0 sites17 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
cancer of the pancreas
Sponsor
niversitair Medisch Centrum Utrecht
Enrollment
17
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients with irresectable locally advanced pancreatic cancer found at laparotomy with histologic diagnosis before start of RFA
  • 2\. Patient considered eligible to undergo pancreatic surgery as assessed by the general criteria of the departments of anaesthesiology and surgery of the UMC Utrecht
  • 3\. Fully informed written consent given

Exclusion Criteria

  • 1\. Patients younger than 18 years
  • 2\. Pregnancy
  • 3\. Patients with distant metastases
  • 4\. Portal vein thrombosis seen on CT preoperatively

Outcomes

Primary Outcomes

Not specified

Similar Trials